Senti Biosciences GAAP EPS of -$0.56

1 hour ago 1

Senti Biosciences press release (NASDAQ:SNTI): Q2 GAAP EPS of -$0.56.
Cash and Cash Equivalents: As of June 30, 2025, Senti Bio held cash and cash equivalents of approximately $21.6 million compared to $48.3 million as of December 31, 2024.

Recommended For You